<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2009-5-4-9-16</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-676</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS</article-title><trans-title-group xml:lang="ru"><trans-title>КОМОРБИДНОСТЬ У БОЛЬНЫХ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ: МЕСТО КАРДИОВАСКУЛЯРНОЙ ПАТОЛОГИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кароли</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Karoli</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра госпитальной терапии</p><p>410012, Саратов, Б. Казачья ул., 112</p></bio><bio xml:lang="en"><p>Chair of Hospital Therapy</p><p>Bolshaya Kazachia ul. 112, Saratov, 410012 </p></bio><email xlink:type="simple">rebrov@sgu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ребров</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Rebrov</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра госпитальной терапии</p><p>410012, Саратов, Б. Казачья ул., 112</p></bio><bio xml:lang="en"><p>Chair of Hospital Therapy</p><p>Bolshaya Kazachia ul. 112, Saratov, 410012 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Саратовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2016</year></pub-date><volume>5</volume><issue>4</issue><fpage>9</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Karoli N.A., Rebrov A.P., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Кароли Н.А., Ребров А.П.</copyright-holder><copyright-holder xml:lang="en">Karoli N.A., Rebrov A.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/676">https://www.rpcardio.online/jour/article/view/676</self-uri><abstract><sec><title>Aim</title><p>Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure) in patients with chronic obstructive pulmonary disease (COPD).</p></sec><sec><title>Material and methods</title><p>Material and methods. 233 patients with COPD (229 men, 4 women; 55,3±0,6 y.o.) were examined. General clinical examination, including body mass index calculation, 6-min walk test, blood analysis, electrocardiography, echocardiography, investigation of respiratory function, pulsoxymetry was carried out. Cardiac Infarction Injury Score (CIIS) index was also evaluated.</p></sec><sec><title>Results</title><p>Results. COPD is associated with arterial hypertension in 62,2% of cases, ischemic heart disease - 27%, carotid atherosclerosis - 43,6%, chronic heart failure in 23,6% of cases. Risk factors of ischemic heart disease in COPD patients include: age, COPD severity, bronchial obstruction severity (decrease of forced expiratory volume), systemic inflammation (high level of C-reactive protein). Patients with severe and very severe COPD had CIIS index &gt;20 1,8 times more often than patients with moderate COPD. Significant correlation of CIIS index with pulmonary hypertension (r=0,21, p&lt;0,05), end-diastolic dimension of right ventricle (r=0,24, p&lt;0,05) and left ventricle (r=0,33, p&lt;0,05), left ventricle ejection fraction (r=-0,40, p&lt;0,01) was found.</p></sec><sec><title>Conclusion</title><p>Conclusion. COPD is associated with cardiovascular diseases. CIIS index can help to detect previous myocardial infarction in COPD patients.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель. Изучить у больных хронической обструктивной болезнью легких (ХОБЛ) частоту встречаемости и особенности течения сердечно-сосудистых заболеваний: артериальной гипертонии (АГ), ишемической болезни сердца (ИБС), хронической сердечной недостаточности (ХСН).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 233 больных ХОБЛ (229 мужчин, 4 женщины; возраст 55,30±0,62 лет). Всем пациентам проводилось общеклиническое обследование, включая определение индекса массы тела, шестиминутный тест с физической нагрузкой, общий анализ крови, ЭКГ, ЭХОКГ, исследование функции внешнего дыхания, пульсоксиметрию. Также определялся индекс CIIS (Cardiac Infarction Injury Score).</p></sec><sec><title>Результаты</title><p>Результаты. ХОБЛ ассоциируется с АГ в 62,2% случаев, ИБС - 27%, атеросклерозом сонных артерий - 43,6% и ХСН в 23,6% случаев. Значимыми факторами риска ИБС у больных ХОБЛ являются возраст, тяжесть течения ХОБЛ и выраженность бронхообструкции (снижение объема форсированного выдоха), системное воспаление (высокий уровень С-реактивного белка). У пациентов с тяжелым и крайне тяжелым течением ХОБЛ индекс CIIS&gt;20 баллов выявлялся в 1,8 раз чаще, чем у пациентов со среднетяжелым течением. Выявлена достоверная связь индекса CIIS с давлением в легочной артерии (r=0,21, p&lt;0,05), конечным диастолическим размером правого (r=0,24, p&lt;0,05) и левого (r=0,33, p&lt;0,05) желудочков, фракцией выброса левого желудочка (r=-0,40, p&lt;0,01).</p></sec><sec><title>Заключение</title><p>Заключение. ХОБЛ ассоциируется с заболеваниями сердечно-сосудистой системы. Индекс CIIS может помочь в выявлении перенесенного инфаркта миокарда у пациентов с ХОБЛ.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь легких</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>коморбидность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic obstructive pulmonary disease</kwd><kwd>cardiovascular diseases</kwd><kwd>comorbidity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple case coding analysis. Eur Respir J 2003;22(5):809-14.</mixed-citation><mixed-citation xml:lang="en">Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple case coding analysis. Eur Respir J 2003;22(5):809-14.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Almagro P., Calbo E., Ochoa de Echagüen A. et al. Mortality after hospitalization for COPD. Chest 2002;121(5):1441–8.</mixed-citation><mixed-citation xml:lang="en">Almagro P., Calbo E., Ochoa de Echagüen A. et al. Mortality after hospitalization for COPD. Chest 2002;121(5):1441–8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Engstrom G., Lind P., Hedblad B. et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002;106(20):2555-60.</mixed-citation><mixed-citation xml:lang="en">Engstrom G., Lind P., Hedblad B. et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002;106(20):2555-60.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Antonelli Incalzi A.R., Fuso L., De Rosa M. et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10(12):2794–800.</mixed-citation><mixed-citation xml:lang="en">Antonelli Incalzi A.R., Fuso L., De Rosa M. et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10(12):2794–800.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107(11):1514-9.</mixed-citation><mixed-citation xml:lang="en">Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107(11):1514-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberg A.L., Watts C. Patients readmitted to ICUs*: a systematic review of risk factors and outcomes. Chest 2000;118(2):492–502.</mixed-citation><mixed-citation xml:lang="en">Rosenberg A.L., Watts C. Patients readmitted to ICUs*: a systematic review of risk factors and outcomes. Chest 2000;118(2):492–502.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Higgins M., Keller J.B., Wagenknecht L.E. et al. Pulmonary function and cardiovascular risk factor relationship in black and in white young men and women. The CARDIA Study. Chest 1991;99(2):315-22.</mixed-citation><mixed-citation xml:lang="en">Higgins M., Keller J.B., Wagenknecht L.E. et al. Pulmonary function and cardiovascular risk factor relationship in black and in white young men and women. The CARDIA Study. Chest 1991;99(2):315-22.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996;348(9027):567-72.</mixed-citation><mixed-citation xml:lang="en">Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996;348(9027):567-72.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Celli B.R., MacNee W.; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46.</mixed-citation><mixed-citation xml:lang="en">Celli B.R., MacNee W.; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Richardson K., Engel G., Yamazaki T. et al. Electrocardiographic damage scores and cardiovascular mortality. Am Heart J 2005;149(3):458-63.</mixed-citation><mixed-citation xml:lang="en">Richardson K., Engel G., Yamazaki T. et al. Electrocardiographic damage scores and cardiovascular mortality. Am Heart J 2005;149(3):458-63.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">van Domburg R.T., Klootwijk P., Deckers J.W. et al. The Cardiac Infarction Injury Score as a predictor for long-term mortality in survivors of a myocardial infarction. Eur Heart J 1998;19(7):1034-41.</mixed-citation><mixed-citation xml:lang="en">van Domburg R.T., Klootwijk P., Deckers J.W. et al. The Cardiac Infarction Injury Score as a predictor for long-term mortality in survivors of a myocardial infarction. Eur Heart J 1998;19(7):1034-41.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dekker J.M., Schouten E.G., Kromhout D. et al. The Cardiac Infarction Injury Score and coronary heart disease in middle-aged and elderly men: the Zutphen Study. J Clin Epidemiol 1995;48(6):833-40.</mixed-citation><mixed-citation xml:lang="en">Dekker J.M., Schouten E.G., Kromhout D. et al. The Cardiac Infarction Injury Score and coronary heart disease in middle-aged and elderly men: the Zutphen Study. J Clin Epidemiol 1995;48(6):833-40.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
